Defined-Formula Diets versus Steroids in the Treatment of Active Crohn's Disease A Meta-Analysis

References

• Ives CW, Hines C. Crohn's disease. Conn's current therapy, RE Rakel. Saunders, Philadelphia 1994; 470–3
   Google Scholar
• Gonzales-Hiux, De Leon R, Fernendez-Banares F, Esteve M, Cabré E, Acero D. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993; 34: 778–82
   PubMedGoogle Scholar
• Lindor KD, Fleming CR, Burnes JU, Nelson JK, Ilstrup DM. A randomised prospective trials comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn's disease. Mayo Clin Proc 1992; 67: 328–33
   PubMed Web of Science ®Google Scholar
• Lochs H, Steinhardt HJ, Klaus-Wentz B, Zeitz M, Vogelsang H, Sommer H. Comparison of enteral nutrition and drug treatment in active Crohn's disease. Gastroenterology 1991; 101: 881–88
   PubMed Web of Science ®Google Scholar
• Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H. Feasibility and effectiveness of defined-formula diet regimen in treating active Crohn's disease. Scand J Gastroenterol 1990; 25: 235–44
   PubMed Web of Science ®Google Scholar
• O'Morain Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ 1984; 288: 1859–62
   PubMedGoogle Scholar
• Saverymuttu S, Hodgson HJF, Chadwick VS. Controlled trial comparing prednisone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut 1985; 26: 994–8
   PubMed Web of Science ®Google Scholar
• Hunt JB, Payne-James JJ, Palmer Kr. A randomised controlled trial of elemental diet and prednisolone as primary therapy in acute exacerbations of Crohn's disease [abstract]. Gastroenterology 1989; 96: A224
   Google Scholar
• Seidman EG, Bouthillier L, Weber AM, Roy CC, Morin CL. Elemental diet versus prednisone as primary treatment of Crohn's disease [abstract]. Gastroenterology 1986; 90: 1625, A.
   Web of Science ®Google Scholar
• Sanderson JR, Udeen S, Davies PSW, Svage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 61: 123–7
   Google Scholar
• O'Keefe SJD, Ogden J, Rund J, Potter P. Steroids and bowel rest versus elemental diet in the treatment of patients with Crohn's disease: the effects on protein metabolism and immune function. J Parent Ent Nutr 1989; 13: 455–60
   PubMed Web of Science ®Google Scholar
• Okada M, Yao T, Yamamoto T, Takenana K, Imamura K, Maeda K. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease. Hepatogastroenterology 1990; 37: 72–80
   PubMedGoogle Scholar
• Riordan AM, Hunter JO, Cowan JR, Crampton JR, Davidson AR, Dickinson RJ. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993; 342: 1131–4
   PubMed Web of Science ®Google Scholar
• Gorard DA, Hunt JB, Payne-James JJ, Palmer KP, Rees RGP, Clark ML. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198–202
   PubMed Web of Science ®Google Scholar
• Hervey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514
   PubMedGoogle Scholar
• Sacks HS, Berrier J, Reitman D, Ancona-Bekr VA, Chalmers TC. Meta-analysis of randomized controlled trials. N Engl J Med 1987; 316: 450–5
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–48
   PubMed Web of Science ®Google Scholar
• Breslow NE, Day NE. Statistical methods in cancer research. Vol. II. The design and analysis of cohort studies. IARC Scientific Publications, Lyon 1987; 109
   Google Scholar
• Der Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 177–88
   PubMedGoogle Scholar
• Woolf B. On estimating the relation between blood group and disease. Ann Human Genet 1955; 9: 251–3
   Google Scholar
• Messori A, Rampazzo R. Meta-analysis of clinical trials based on censored end-points: simplified theory and implementation of the statistical algorithms on a microcomputer. Comput Progr Biomed 1993; 40: 261–7
   Google Scholar
• Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728–33
   PubMed Web of Science ®Google Scholar
• Simes RJ. Confronting publication bias: a cohort design for meta-analysis. Stat Med 1987; 6: 11–29
   PubMed Web of Science ®Google Scholar
• Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993; 269: 2749–53
   PubMed Web of Science ®Google Scholar
• Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 1986; 58: 1378–86
   PubMed Web of Science ®Google Scholar
• Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351–5
   PubMed Web of Science ®Google Scholar
• Collins R, Yusuf S, Peto R. Overview of randomised trials of diuretics in pregnancy. BMJ 1985; 290: 17–25
   PubMed Web of Science ®Google Scholar
• Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Metaanalysis of enteral nutrition as primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056–67
   PubMed Web of Science ®Google Scholar
• Lau J, Antman EM, Jimenez-Silva J, Kupelink B, Mosteller SF, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248–54
   PubMed Web of Science ®Google Scholar